MyD88-dependent nuclear factor-κB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes

Journal of Hypertension

Volumn 27, Issue 5, 2009, Pages 1084-1093

  Li, Ting ^a   Wang, Yongmei ^a   Liu, Chunyang ^a   Hu, Yulong ^a   Wu, Meiling ^a   Li, Jing ^a   Guo, Lin ^a   Chen, Liang ^a   Chen, Qi ^a   Ha, Tuanzhu ^b   Li, Chuanfu ^b   Li, Yuehua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b East Tennessee State University   (United States)

Author keywords

Cardiomyocyte; Cell culture; Hypertrophy; Receptors; Signal transduction

Indexed keywords

ATRIAL NATRIURETIC FACTOR; FIBRINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SURGERY; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

EID: 67649817478     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283293c93     Document Type: Article

References (38)

1. Massberg S, Enders G, Matos FC, Tomic LI, Leiderer R, Eisenmenger S, et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 1999; 94:3829-3838.
2. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167:2887-2894.
3. Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J. Regulation of extravascular coagulation by microvascular permeability. Science 1985; 227:1059-1061.
4. Sahni A, Francis CW. Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires αvβ3. Blood 2004; 104:3635-3641.
5. Gray AJ, Bishop JE, Reeves JT, Laurent GJ. A alpha and B beta chains of fibrinogen stimulate proliferation of human fibroblasts. J Cell Sci 1993; 104:409-413.
6. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2629-2631.
7. Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294:1799-1809.
8. Palmieri V, Celentano A, Roman MJ, de Simone G, Lewis MR, Best L, et al. Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study. Hypertension 2001; 38:1068-1074.
9. Orr AW, Sanders JM, Bevard M, Coleman E, Sarembock IJ, Schwartz MA. The subendothelial extracellular matrix modulates NF-KB activation by flow: a potential role in atherosclerosis. J Cell Biol 2005; 169:191-202.
10. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 1995; 25:83-90.
11. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, etal. Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest 2003; 33:561-566.
12. Kobayashi S, Yano M, Kohno M, Obayashi M, Hisamatsu Y, Ryoke T, et al. Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation 1996; 94:3362-3368.
13. Rodriguez-Porcel M, Zhu XY, Chade AR, Amores-Arriaga B, Caplice NM, Ritman EL, et al. Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension. Am J Physiol Heart Circ Physiol 2006; 290:978-984.
14. McPherson JA, Barringhaus KG, Bishop GG, Sanders JM, Rieger JM, Hesselbacher SE, et al. Adenosine A (2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 2001; 21:791-796.
15. Wåhlander H, Haraldsson B, Friberg P. Myocardial capillary diffusion capacity in rat hearts with cardiac hypertrophy due to pressure and volume overload. Am J Physiol 1993; 265:61-68.
16. Nicoletti A, Michel JB. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 1999; 41:532-543.
17. Ren J, Avery J, Zhao H, Schneider JG, Ross FP, Muslin AJ. b3 Integrin deficiency promotes cardiac hypertrophy and inflammation. J Mol Cell Cardiol 2007; 42:367-377.
18. Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, et al. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 2002; 39:907-912.
19. Petersen CA, Krumholz KA, Burleigh BA. Toll-like receptor 2 regulates interleukin-1 beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect Immun 2005; 10:6974-6980.
20. Condorelli G, Morisco C, Latronico MV, Claudio PP, Dent P, Tsichlis P. TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J 2002; 13:1732-1737.
21. Akira S, Takeda K. Toll like receptor signaling. Nature Rev Immunol 2004; 4:499-511.
22. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007; 4:444-454.
23. Li Y, Ha T, Gao X, Kelley J, Williams DL, Browder IW, et al. NF-kappaB activation is required for the development of cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 2004; 287:1 712-1 720.
24. Ha T, Li Y, Hua F, Ma J, Gao X, Kelley J, etal. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 2005; 68:224-234.
25. Ha T, Hua F, Li Y, Ma J, Gao X, Kelley J, etal. Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 2006; 290:985-994.
26. Sitrin RG, Pan PM, Srikanth S, Todd RF. Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol 1998; 161:1462-1470.
27. Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001; 108:1429-1437.
28. Edelberg JM, Aird WC, Rosenberg RD. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest 1998; 101:337-343.
29. Chen H, Huang XN, Stewart AF, Sepulveda JL Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiol Genomics 2004; 18:273-283.
30. Li J, Wu M, Que L, Wang Y, Xu X, Hu Y, et al. 17beta-Estradiol attenuates cardiac dysfunction and decreases NF-kappaB binding activity in mechanically stretched rat hearts. Steroids 2008; 73:720-726.
31. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 2001; 12:6668-6673.
32. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL Modulating Toll-like receptor mediated signaling by (1->3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res 2004; 3:538-547.
33. Shekhonin BV, Guriev SB, Irgashev SB, Koteliansky VE. Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction. J Mol Cell Cardiol 1990; 22:533-541.
34. Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 2006; 26:2793-2799.
35. Shekhonin BV, Guriev SB, Irgashev Sh B, Kotelianski VE. Fibronectin and fibrinogen/fibrin at the focus of an experimental myocardial infarct. Arkh Patol 1989; 51:14-20.
36. Boyd JH, Chau EH, Tokunanga C, Bateman RM, Haljan G, Davani EY, et al. Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism. Crit Care 2008; 12:R2; Published online 2008 January 3. doi: 10.1186/cc6213.R2.
37. Wang YM, Li T, Hu YL, Li J, Chen L, Li YH. Nuclear factor-κB is required for pressure overload-induced heart failure. Acta Univ Med Nanjing 2007; 27:777-780.
38. Herwald H, Cramer H, Mörgelin M, Russell W, Sollenberg U, Norrby-Teglund A, et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004; 116:367-379.